Employee Benefit Plans (Tables)

9 Months Ended

Mar. 31, 2019

Share Based Compensation [Abstract]

Shares Reserved for Issuance

The Company had reserved for issuance for the periods noted (in thousands):

	March 31, 2019		June 30, 2018
2013 Equity Incentive Plan shares available for grant		8,092		9,957
Employee stock options and awards outstanding		11,192		12,060
2014 Employee Stock Purchase Plan		10,085		5,365
Total shares reserved for issuance		29,369		27,382

Schedule of Recognized Share-based Compensation Expense

Share-based compensation expense recognized in the condensed consolidated financial statements by line item caption is as follows (in thousands):

	Three Months Ended				Nine Months Ended
	March 31, 2019		March 31, 2018		March 31, 2019		March 31, 2018
Cost of product revenue	$	223	$	163	$	618	$	389
Cost of service revenue		648		354		1,670		783
Research and development		2,814		2,367		7,953		5,247
Sales and marketing		3,187		2,735		8,529		7,077
General and administrative		1,942		2,199		5,569		6,150
Total share-based compensation expense	$	8,814	$	7,818	$	24,339	$	19,646

Summary of Stock Award Activity

The following table summarizes stock award activity for the nine months ended March 31, 2019 (in thousands, except grant date fair value):

	Number of Shares			Weighted- Average Grant Date Fair Value		Aggregate Fair Market Value
Non-vested stock awards outstanding at June 30, 2018		7,764		$	8.60	$	61,804
Granted		4,516			6.44
Released		(2,909	)		7.92
Cancelled		(921	)		8.74
Non-vested stock awards outstanding at March 31, 2019		8,450		$	7.66	$	63,280

Summary of Stock Option Activity

The following table summarizes stock option activity for the nine months ended March 31, 2019 (in thousands, except per share and contractual term):

	Number of Shares			Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Options outstanding at June 30, 2018		2,193		$	3.88		2.90	$	8,996
Granted		852			6.40
Exercised		(216	)		3.73
Cancelled		(87	)		6.01
Options outstanding at March 31, 2019		2,742		$	4.60		3.48	$	7,947
Vested and expected to vest at March 31, 2019		2,742		$	4.60		3.48	$	7,947
Exercisable at March 31, 2019		1,974		$	3.90		2.33	$	7,097

Schedule of Fair Value Assumptions for Stock Options and Employee Stock Purchase Plan Awards

The following assumptions were used to calculate the fair value of shares granted under the ESPP during the following periods:

	Employee Stock Purchase Plan						Employee Stock Purchase Plan
	Three Months Ended						Nine Months Ended
	March 31, 2019			March 31, 2018			March 31, 2019			March 31, 2018
Expected life	0.5 years			0.5 years			0.5 years			0.5 years
Risk-free interest rate		2.46	%		1.15	%		2.35	%	1.64%-1.15%
Volatility		75	%		42	%		70	%		42	%
Dividend yield		—	%		—	%		—	%		—	%